# Correction to “Better Response and Prognosis of Venetoclax Plus Hypomethylating Agents Over Intensive Chemotherapy in Young Adults With Newly Diagnosed ASXL1‐Mutated Acute Myeloid Leukemia”

PMC · DOI: 10.1002/cam4.71141 · Cancer Medicine · 2025-08-08

## Full-text entities

- **Genes:** ASXL1 (ASXL transcriptional regulator 1) [NCBI Gene 171023] {aka BOPS, MDS}
- **Diseases:** Acute Myeloid Leukemia (MESH:D015470)
- **Chemicals:** Venetoclax (MESH:C579720)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12332531/full.md

---
Source: https://tomesphere.com/paper/PMC12332531